Display Settings:

Format

Send to:

Choose Destination
    Clin Liver Dis. 2007 Aug;11(3):563-75, vi-vii.

    Nonsteroidal anti-inflammatory drug-induced hepatotoxicity.

    Source

    Queen's Medical Centre, University Hospital, D Floor, South Block, Nottingham, NG7 2UH, UK. guru.aithal@nuh.nhs.uk

    Abstract

    Nonsteroidal anti-inflammatory drugs are among the most common drugs associated with drug-induced liver injury, with an estimated incidence of between 3 and 23 per 100,000 patient years. Nimesulide, sulindac, and diclofenac seem to be associated with the highest risk and the only risk factor consistently identified is the concomitant use of other hepatotoxic drugs. Diclofenac-induced liver injury is a paradigm for drug-related hepatotoxicity. Recent studies suggest that genetic factors favoring the formation and accumulation of the reactive acylglucuronide metabolite of diclofenac and an enhanced immune response to the metabolite-protein adducts are associated with increased susceptibility to hepatotoxicity.

    PMID:
    17723920
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk